DJIA 17,131.97 100.83 0.59%
NASDAQ 4,552.76 33.86 0.75%
S&P 500 1,998.98 14.85 0.75%
market minute promo

SPDR S&P Biotech (ETF) (NYSEMKT: XBI)

157.76 0.85 (0.54%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

XBI $157.76 0.54%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $155.92
Previous Close $156.91
Daily Range $155.00 - $157.88
52-Week Range $113.22 - $172.52
Market Cap $1.2B
Dividend (Yield) $2.46 (0.7%)
Volume 336,922
Average Daily Volume 271,091

News & Commentary Rss Feed

1 of These 3 Cratering Biotechs Is a Buy

Biotech stocks have been performing poorly in general this year. However, some biotechs have been having a truly terrible year. Here's a look at the three worst-performing biotechs and their respective chances at making a comeback.

Wednesday's ETF Movers: XBI, GDXJ

Friday's ETF Movers: XLU, XBI

ALNY Makes Notable Cross Below Critical Moving Average

Biotechnology ETFs Show Robust Health In August

Friday's ETF Movers: XBI, PIZ

After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary

Biotech ETFs Surge on InterMune-Roche Deal - ETF News And Commentary

Tuesday's ETF Movers: XBI, XLU

Biotech Stock Boom Times Are Back

Alnylam Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ALNY

See More XBI News...

Sector

Sector Equity

Industry

Health/Biotechnology Funds

SPDR S&P Biotech (ETF) (XBI) Description

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index. Website: http://www.spdrs.com/